Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol.

No abstract is available for this paper.

• Publication year

  1979

• Venue

  Journal of Pharmacy and Science

• Publication date

  1979-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/JPS.2600681106PMID 41932
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The influence of cigarette smoking and sex on theophylline disposition.

  2015cited by this paper
• Rapid evaluation of creatinine clearance.

  2009cited by this paper
• Drug Actions Interactions & Reactions

  1978cited by this paper
• Pharmacokinetics of theophylline in hepatic disease.

  1978cited by this paper
• ALTERED THEOPHYLLINE PHARMACOKINETICS DURING ACUTE RESPIRATORY VIRAL ILLNESS

  1978cited by this paper
• Theophylline disposition in obesity

  1978cited by this paper
• Enhanced biotransformation of theophylline in marihuana and tobacco smokers

  1978cited by this paper
• Studies on theobromine disposition in normal subjects; Alterations induced by dietary abstention from or exposure to methylxanthines

  1978cited by this paper
• Effects of an oral contraceptive on hepatic size and antipyrine metabolism in premenopausal women

  1978cited by this paper
• Role of tobacco smoking in pharmacokinetics

  1978cited by this paper
• 152. The pharmacokinetics of theophylline in pregnancy

  1978cited by this paper
• Clinical Pharmacokinetics of Theophylline

  1978cited by this paper
• Effect of phenobarbital on theophylline disposition.

  1978cited by this paper
• Absolute bioavailability of oral theophylline.

  1977cited by this paper
• Intravenous theophylline therapy: nomogram guidelines.

  1977cited by this paper
• Theophylline kinetics in acute pulmonary edema

  1977cited by this paper
• Dose-dependent kinetics of theophylline disposition in asthmatic children.

  1977cited by this paper
• Variation in theophylline clearance rate with time in chronic childhood asthma.

  1977cited by this paper
• Theophylline disposition in patients with hepatic cirrhosis.

  1977cited by this paper
• Mortality among oral-contraceptive users. Royal College of General Practitioners' Oral Contraception Study.

  1977cited by this paper
• Estimation of population characteristics of pharmacokinetic parameters from routine clinical data

  1977cited by this paper
• Effect of phenobarbital on the disposition of intravenous theophylline

  1977cited by this paper
• Administration of erythromycin to patients on theophylline.

  1977cited by this paper
• Apparent theophylline half-life fluctuations during treatment of acute left ventricular failure.

  1977cited by this paper
• Inhibition of theophylline clearance by troleandomycin.

  1977cited by this paper
• The Effect of Disease States on Drug Pharmacokinetics

  1977cited by this paper
• System for clinical pharmacokinetic monitoring of theophylline therapy.

  1976cited by this paper
• PHENYTOIN and PHENOBARBITONE PLASMA CLEARANCE DURING PREGNANCY

  1976cited by this paper
• The effect of arterial oxygen tension on antipyrine half‐time in plasma

  1976cited by this paper
• Cigarette smoking, use of oral contraceptives, and myocardial infarction.

  1976cited by this paper
• Pharmacokinetic aspects of theophylline in premature newborns.

  1976cited by this paper
• Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man

  1976cited by this paper
• Intravenous aminophylline dosage. Use of serum theophylline measurement for guidance.

  1976cited by this paper
• Theophylline secretion into breast milk.

  1976cited by this paper
• High-pressure liquid chromatographic and spectrophotometric assays for theophylline in biological fluids.

  1976cited by this paper
• Pharmacokinetic analysis of the disposition of intravenous theophylline in young children.

  1976cited by this paper
• Theophylline metabolism by the rat liver microsomal system.

  1976cited by this paper
• Ethanol metabolism and ethanol-drug interactions.

  1976cited by this paper
• Theophylline pharmacokinetics in premature infants with apnea.

  1976cited by this paper
• Effect of smoking on theophylline disposition

  1976cited by this paper
• Pharmacokinetics of theophylline in children with asthma.

  1976cited by this paper
• Effects of alteration of hepatic microsomal enzyme activity on liver blood flow in the rat.

  1976cited by this paper
• Letter: Serotyping of E. coli.

  1976cited by this paper
• Relationship of urinary metabolites of theophylline to serum theophylline levels

  1976cited by this paper
• Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicity.

  1976cited by this paper
• Sex as a factor in metabolism, toxicity, and efficacy of pharmacodynamic and chemotherapeutic agents.

  1975cited by this paper
• Pharmacokinetics in the aged: A review

  1975cited by this paper
• Digoxin pharmacokinetics: Role of renal failure in dosage regimen design

  1975cited by this paper
• Decreased theophylline half-life in cigarette smokers.

  1975cited by this paper
• Altered plasma half‐lives of antipyrine, propylthiouracil, and methimazole in thyroid dysfunction

  1975cited by this paper
• Clinical Pharmacokinetics: A Symposium

  1975cited by this paper
• The effects of age and liver disease on the disposition and elimination of diazepam in adult man.

  1975cited by this paper
• Relationship between theophylline concentration in plasma and saliva of man

  1974cited by this paper
• Hepatic and metabolic effects of alcohol (1966 to 1973).

  1973cited by this paper
• The liver in congestive heart failure: a review.

  1973cited by this paper
• Rational intravenous doses of theophylline.

  1973cited by this paper
• Stimulation of drug metabolism in man by tricyclic antidepressants

  1973cited by this paper
• Pharmacokinetics of intravenous theophylline

  1973cited by this paper
• Computer-assisted digoxin therapy.

  1973cited by this paper
• Pharmacokinetics of theophylline; Application to adjustment of the clinical dose of aminophylline

  1972cited by this paper
• Drug therapy. Serum drug concentrations as therapeutic guides.

  1972cited by this paper
• Modelling of individual pharmacokinetics for computer-aided drug dosage.

  1972cited by this paper
• Effect of Age and Sex on Human Drug Metabolism

  1971cited by this paper
• Rapid evaluation of creatinine clearance.

  1971cited by this paper
• Rapid evaluation of creatinine clearance.

  1971cited by this paper
• Documenta Geigy Scientific Tables

  1970cited by this paper
• The effect of caffeine on drug metabolism.

  1968cited by this paper
• Pharmacological implications of microsomal enzyme induction.

  1967cited by this paper
• Applied Regression Analysis.

  1967cited by this paper
• Blood volume, cardiac output, and distribution of systemic blood flow in extreme obesity.

  1962cited by this paper
• The liver in congestive heart failure.

  1955cited by this paper
• An ultraviolet spectrophotometric method for the determination of theophylline and theobromine in blood and tissues.

  1949cited by this paper

• Cannabidiol and Δ9-tetrahydrocannabinol induce drug-metabolizing enzymes, but not transporters, in human hepatocytes: Implications for predicting complex cannabinoid-drug interactions.

  2025cites this paper
• CBD and THC in Special Populations: Pharmacokinetics and Drug–Drug Interactions

  2024cites this paper
• Current status and usefulness of therapeutic drug monitoring implementation of theophylline in elderly patients based on a nationwide database study and modeling approach

  2024cites this paper
• Pharmacological interactions and menopausal hormone therapy: a review

  2023cites this paper
• Pharmacokinetics of obese adults: Not only an increase in weight.

  2023cites this paper
• Clinical Relevance of Drug Interactions with Cannabis: A Systematic Review

  2022cites this paper
• Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group.

  2022cites this paper
• Analysis of drug adverse events in elderly patients based on the Japanese Adverse Drug Event Report Database

  2022cites this paper
• Effect of liver cirrhosis on theophylline trough concentrations: A comparative analysis of organ impairment using Child–Pugh and MELD scores

  2022cites this paper
• Cannabinoid-Based Medicine: Pharmacology and Drug Interactions

  2022cites this paper
• Reduced theophylline clearance due to hepatic congestion secondary to right heart failure - A population pharmacokinetic study.

  2021cites this paper
• Pharmacokinetics and Pharmacodynamics of Drugs in Obese Pediatric Patients: How to Map Uncharted Clinical Territories.

  2019cites this paper
• The Potential for Pharmacokinetic Interactions Between Cannabis Products and Conventional Medications.

  2019cites this paper
• Adverse pharmacokinetic interactions between illicit substances and clinical drugs

  2019cites this paper
• In Vitro Inhibition of Carboxylesterase 1 by Major Cannabinoids and Selected Metabolites

  2019cites this paper
• A Review of Cannabis in Chronic Kidney Disease Symptom Management

  2019cites this paper
• Medical cannabis: A new frontier for pharmacists

  2019cites this paper
• How to Manage Drug Interactions in Clinical Settings (2)

  2018cites this paper
• Pharmacogenomics and Psychiatric Clinical Care.

  2018cites this paper
• The influence of heart failure on the pharmacokinetics of cardiovascular and non‐cardiovascular drugs: a critical appraisal of the evidence

  2018cites this paper
• Maximizing Safety and Efficacy

  2017cites this paper
• A systematic in vitro metabolism study of opioids using rat liver S9 fractions and mass spectrometry revealed CYP2D metabolism is impaired with age

  2017cites this paper
• Be aware that the use of tobacco, cannabinoids and smoking cessation may result in pharmacokinetic interactions with other drugs

  2017cites this paper
• Be aware that the use of tobacco, cannabinoids and smoking cessation may result in pharmacokinetic interactions with other drugs

  2017cites this paper
• Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines.

  2017cites this paper
• Application of a Physiologically Based Pharmacokinetic Model to Study Theophylline Metabolism and Its Interactions With Ciprofloxacin and Caffeine

  2016cites this paper
• Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products

  2016cites this paper
• Case Report: The risks associated with chronic theophylline therapy and measures designed to improve monitoring and management

  2016cites this paper
• Medical marijuana: Between a plant and a hard place.

  2015cites this paper
• Clinical Pharmacokinetics and Pharmacodynamics

  2014cites this paper
• Drug interactions with Marijuana

  2014cites this paper
• Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review

  2014cites this paper
• The influence of morbid obesity on the pharmacokinetics and pharmacodynamics of drugs in adolescents and adults : focus on propofol and nadroparin

  2013cites this paper
• The influence of morbid obesity on the pharmacokinetics and pharmacodynamics of drugs in adolescents and adults : focus on propofol and nadroparin.

  2013cites this paper
• EFFECT OF OBESITY ON HEPATIC DRUG METABOLISM

  2013cites this paper
• Pharmacologie de la morphine chez les sujets obèses avant et après chirurgie de l'obésité

  2013cites this paper
• Stochastic control methods to individualise drug therapy by incorporating pharmacokinetic, pharmacodynamic and adverse event data

  2013cites this paper
• Theophylline and its interactions 1

  2013influential citation
• Impact of the pharmaceutical sciences on health care: a reflection over the past 50 years.

  2012cites this paper
• Impact of Obesity on Drug Metabolism and Elimination in Adults and Children

  2012cites this paper
• Clinical Pharmacokinetic Considerations in the Elderly

  2012cites this paper
• Pharmacokinetics and metabolism of natural methylxanthines in animal and man.

  2011cites this paper
• A new definition of pharmaceutical quality: assembly of a risk simulation platform to investigate the impact of manufacturing/product variability on clinical performance.

  2010cites this paper
• Chapter 50 – Theophylline

  2009cites this paper
• Individualization of oral theophylline dosage in elderly patients.

  2009cites this paper
• Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development.

  2009cites this paper
• Performance-Based Quality Specifications: The Link between Product Development and Clinical Outcomes

  2009influential citation
• Advocating for patients through clinical research.

  2008cites this paper
• Serum and Saliva Theophylline Levels in Adult Outpatients with Asthma and Chronic Obstructive Pulmonary Disease (COPD): A Cross-Sectional Study

  2008cites this paper
• The role of the liver in theophylline elimination

  2007cites this paper
• Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics

  2007cites this paper
• Drug Therapy in the Elderly

  2007cites this paper
• The Current State of Knowledge on Age, Sex, and Their Interactions on Clinical Pharmacology

  2007cites this paper
• Estimation of pharmacokinetic parameters based on the patient-adjusted population data.

  2006cites this paper
• Individualizing theophylline dosage: Evaluation of a single-point maintenance dose prediction method

  2004influential citation
• Determination of theophylline clearance in South African children

  2004cites this paper
• A “once a day administration” sustained-release theophylline formulation: Disposition and pharmacokinetics

  2004cites this paper
• The relationship between clearance of theophylline and age within the adult age range

  2004cites this paper
• Components of variability in serum theophylline concentrations during maintenance therapy with a sustained release formulation

  2004cites this paper
• Effect of chronic oral contraceptive steroids on theophylline disposition

  2004cites this paper
• Pharmacokinetic Behavior of Theophylline following PEEP in Critically Ill Patients with Acute Lung Injury

  2004cites this paper
• Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit I. Single dose study

  2004cites this paper
• The pharmacokinetics of theophylline and enprofylline in patients with liver cirrhosis and in patients with chronic renal disease

  2004influential citation
• Personality and theophylline pharmacokinetics

  2004cites this paper
• Aging, cigarette smoking and oral theophylline requirement

  2004cites this paper
• Pharmacokinetics of theophylline in patients following short-term intravenous infusion

  2004influential citation
• The relationship between theophylline clearance and age in adult life

  2004cites this paper
• Longitudinal effects of pregnancy on the pharmacokinetics of theophylline

  2004influential citation
• Individualized aminophylline therapy in patients with obstructive airway disease: Oral dosage prediction from an intravenous test dose

  2004cites this paper
• Sex-related differences in theophylline pharmacokinetics

  2004cites this paper
• Pharmacokinetics of theophylline in Ethiopian children of differing nutritional status

  2004cites this paper
• Population pharmacokinetics of theophylline during paediatric extracorporeal membrane oxygenation.

  2003cites this paper
• Pharmacokinetics of an ultralong sustained‐release theophylline formulation when given twice daily in elderly patients with chronic obstructive pulmonary disease: Monitoring implications

  2003cites this paper
• Differential Pharmacokinetics of Theophylline in Elderly Patients

  2003cites this paper
• Chapter 51 – Theophylline

  2002cites this paper
• Influence of Concomitant Administrations on the Clearance of Theophylline as Analyzed by Population Pharmacokinetics

  2001cites this paper
• Pharmacokinetics: Interactions of New Drugs and the Human Body

  2000cites this paper
• Theophylline for the treatment of bronchial asthma: present status.

  2000cites this paper
• Effect of disease states on theophylline serum concentrations: are we still vigilant?

  2000cites this paper
• Pharmacokinetics: Interactions of New Drugs and the Human Body

  2000cites this paper
• A review of clinical use of theophylline in acute asthma: factors influencing kinetic disposition and drug interactions.

  2000cites this paper
• Pharmacotherapy of chronic asthma.

  1999cites this paper
• Effects of obesity on the cytochrome P450 enzyme system.

  1999cites this paper
• Biotransformation of theophylline in cirrhotic rats induced by biliary obstruction

  1999cites this paper
• Controlled-release hydrophilic tablets for individualized theophylline therapy.

  1999cites this paper
• [Population pharmacokinetic analysis of theophylline: relationship between serum concentrations and clinical effects in therapeutic drug monitoring].

  1999cites this paper
• Physiological and Pharmacological Interactions of Marihuana (THC) with Drugs and Anesthetics

  1999cites this paper
• Aging and drug interactions. III. Individual and combined effects of cimetidine and cimetidine and ciprofloxacin on theophylline metabolism in healthy male and female nonsmokers.

  1997cites this paper
• Aging and Drug Interactions. III. Individual and Combined Effects of Cimetidine and Ciprofloxacin on Theophylline Metabolism in Healthy Male and Female Nonsmokers

  1997cites this paper
• CHAPTER 3 – Drug Interactions with Agents Used in Respiratory Disease

  1997cites this paper
• Comparative study on the clinical efficacy of theophylline variable serum concentrations therapy and round-the-clock therapy.

  1997cites this paper
• Acute and chronic human toxicity of theophylline

  1996cites this paper
• Reduction of the central nervous system adverse effects associated with antihistamines in the management of allergic disorders: strategies and progress.

  1996cites this paper
• Application of population pharmacokinetics to the optimization of theophylline therapy

  1996cites this paper
• Pharmacokinetic Dosing Algorithms

  1995cites this paper
• Prevention of drug absorption in simulated theophylline overdose.

  1995cites this paper
• Evolving role of theophylline for treatment of chronic childhood asthma.

  1995cites this paper
• Effects of chronic left ventricular failure on hepatic oxygenation and theophylline elimination in the rat.

  1995cites this paper
• Role of pharmacokinetics and pharmacodynamics in the design of dosage schedules for 12-h cefotaxime alone and in combination with other antibiotics.

  1995cites this paper
• Theophylline-ranitidine interaction in elderly COPD patients.

  1995cites this paper